Judi works the same way across every therapeutic area and indication, from early-phase studies through post-marketing surveillance. The platform is configured to your exact protocol and operational plans and scales with your needs. Backed by decades of experience, AG Mednet is your essential partner in simplifying complex trials and getting to better decisions faster.
Oncology protocols are among the most complex in clinical research. Patients move through progressive cohorts that need screening coordination. Inclusion and exclusion criteria are detailed and often subjective, so eligibility decisions have to be centralized. Imaging drives the endpoints, most studies need a DSMB and those endpoints often require both clinical event and imaging-based adjudication.
Judi brings all of that oversight into one place. Screening coordination, centralized eligibility, clinical event and imaging-based adjudication, and DSMB reporting run in a single configured workspace, so no one is tracking cohort assignments in spreadsheets or chasing scans by email. Work routes to the right reviewer with the records already attached, so decisions move instead of waiting on someone to find a file. Every action is timestamped, which means the trial stays audit ready rather than getting reconstructed at the end.
Cardiometabolic trials run for years across hundreds of global sites and thousands of patients, with layers of expert oversight: centralized eligibility, DSMB, and clinical event and image-based endpoint adjudication. Sequencing these specialized panels is challenging. For example, each DSMB review needs a high threshold of adjudicated endpoints, and database lock hinges on adjudication finishing on time, so boluses of unprocessed patient records put every downstream decision at risk.
Judi replaces the manual collection and processing with one structured workspace that tracks and records every task, so endpoint status stays visible throughout the study.
Judi is a clinical trial optimization platform supporting trials across more than 20 therapeutic areas, including oncology, cardiometabolic disease, rare and orphan indications, respiratory, endocrinology, immunology, infectious disease, hematology, gynecology and psychiatry. Each trial is configured to its own protocol and SOPs rather than to a fixed template. To date Judi has supported trials across more than 70,000 sites and 120 countries.
To the protocol and the operational plan: data flow, endpoints, inclusion and exclusion criteria, chartered processes, review pathways and committee structures. Configuration is customizable, so a trial is never forced to fit a template.
Yes. A protocol amendment or device change is handled in the configuration, not the software, so it moves through formal change control rather than a new build. AG Mednet documents the request, assesses impact and risk, and scopes the work. On client approval, the change moves through build, system testing, user acceptance testing and deployment, and the trial configuration specification is up-versioned and re-approved. Where a test trial exists, changes are built and validated there before deployment to the live trial. An expedited path is available.
AG Mednet has configured clinical trial workflows across more than 20 therapeutic areas, covering more than 2,500 trials, over 70,000 sites in 120+ countries and more than 350 Phase III studies.
Yes. More than 1,000 oncology trials run on Judi.
Yes. Judi supports rare disease and orphan indication research, designed for small, geographically dispersed populations: centralized eligibility review so patient enrollment is confirmed for protocol compliance, remote monitoring that scales from a single site to a global program, specialized imaging reviewed centrally, and adjudication configured for endpoints with no established precedent.
Yes. Remote SDV cuts the travel and on-site time that drive monitoring cost. Sponsors using Judi report 86 percent lower cost per monitoring visit, 60 percent fewer labor hours per visit and 43 percent lower overall trial costs.
Images upload directly from the site, are de-identified at two layers, DICOM tags and pixel redaction, quality-checked at upload and reviewed centrally, so reviewers open complete data and work on the endpoints that gate the study.
Yes. Judi is SOC 2 Type 2 certified and holds active certification under the EU-U.S. Data Privacy Framework, including the UK Extension and the Swiss-U.S. DPF. The SOC 2 examination is an independent CPA review of the design and operating effectiveness of our security controls, performed every year since 2021, with no exceptions noted in the most recent report. Judi operates as a data processor and business associate on behalf of sponsors and CROs, and is designed and validated to support your 21 CFR Part 11, HIPAA and GDPR obligations, covering electronic records and signatures, audit trails and access controls. Trial data is collected, processed and reviewed in a validated, access-controlled platform, with every action captured in a timestamped audit trail. AG Mednet supports client security questionnaires, vendor assessments and audits as part of standard engagement, and can share evidence on request.